[go: up one dir, main page]

PL355172A1 - Oncolytic combinations for the treatment of cancer - Google Patents

Oncolytic combinations for the treatment of cancer

Info

Publication number
PL355172A1
PL355172A1 PL00355172A PL35517200A PL355172A1 PL 355172 A1 PL355172 A1 PL 355172A1 PL 00355172 A PL00355172 A PL 00355172A PL 35517200 A PL35517200 A PL 35517200A PL 355172 A1 PL355172 A1 PL 355172A1
Authority
PL
Poland
Prior art keywords
cancer
treatment
oncolytic
combinations
oncolytic combinations
Prior art date
Application number
PL00355172A
Other languages
Polish (pl)
Inventor
Jerome Herbert Fleisch
Roger Stuart Benjamin
Jason Scott Sawyer
Beverly Ann Teicher
Douglas Wade Beight
Edward C.R. Smith
William Thomas Mcmillen
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of PL355172A1 publication Critical patent/PL355172A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
PL00355172A 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer PL355172A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16478699P 1999-11-11 1999-11-11
PCT/US2000/031039 WO2001034137A2 (en) 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer

Publications (1)

Publication Number Publication Date
PL355172A1 true PL355172A1 (en) 2004-04-05

Family

ID=22596085

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00355172A PL355172A1 (en) 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer

Country Status (22)

Country Link
EP (1) EP1231938A2 (en)
JP (1) JP2003513916A (en)
KR (1) KR20020069512A (en)
CN (1) CN1390139A (en)
AR (1) AR032432A1 (en)
AU (1) AU778829B2 (en)
BR (1) BR0015490A (en)
CA (1) CA2391416A1 (en)
CZ (1) CZ20021551A3 (en)
EA (1) EA200200545A1 (en)
HK (1) HK1050132A1 (en)
HU (1) HUP0204449A3 (en)
IL (1) IL148579A0 (en)
MX (1) MXPA02004733A (en)
NO (1) NO20022245L (en)
NZ (1) NZ517667A (en)
PE (1) PE20010701A1 (en)
PL (1) PL355172A1 (en)
SK (1) SK6492002A3 (en)
TR (1) TR200201245T2 (en)
WO (1) WO2001034137A2 (en)
ZA (1) ZA200202822B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797723B1 (en) 1999-11-11 2004-09-28 Eli Lilly And Company Heterocycle substituted diphenyl leukotriene antagonists
AU1916501A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
AU1916601A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2001247459A (en) 2000-03-03 2001-09-11 Oakland Uniservices Ltd Cancer combination therapy
WO2001085166A1 (en) * 2000-05-09 2001-11-15 Creighton University Methods for inhibiting proliferation and inducing apoptosis in cancer cells
JP2004505047A (en) 2000-07-28 2004-02-19 キャンサー・リサーチ・テクノロジー・リミテッド Cancer treatment by combined therapy
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
US8053598B2 (en) 2004-05-05 2011-11-08 High Point Pharmaceuticals, Llc Compounds, their preparation and use
ATE486055T1 (en) 2004-05-05 2010-11-15 High Point Pharmaceuticals Llc NEW COMPOUNDS, THEIR PRODUCTION AND USE
CN1302782C (en) * 2005-01-17 2007-03-07 北京京卫燕康药物研究所有限公司 Jixitabing hydrochloride solution type injection agent
JP5052511B2 (en) 2005-06-30 2012-10-17 ハイ ポイント ファーマシューティカルズ,エルエルシー Phenoxyacetic acid as a PPAR delta activator
CA2631390C (en) 2005-12-22 2014-03-11 Per Sauerberg Phenoxy acetic acids as ppar delta activators
JP2009529512A (en) 2006-03-09 2009-08-20 ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー Novel compounds, methods for their production and use
JP5207972B2 (en) 2006-10-12 2013-06-12 株式会社医薬分子設計研究所 Carboxylic acid derivatives
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
WO2014060381A1 (en) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclic compounds as pesticides
CN104884449A (en) 2012-10-31 2015-09-02 拜尔农作物科学股份公司 Novel heterocyclic compounds as pest control agents
CN103319466B (en) * 2013-07-04 2016-03-16 郑州大学 Containing the 1,2,3-triazoles-dithiocarbamates compound of tonka bean camphor parent nucleus, preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
BR0015490A (en) 2002-07-09
EP1231938A2 (en) 2002-08-21
IL148579A0 (en) 2002-09-12
AR032432A1 (en) 2003-11-12
WO2001034137A2 (en) 2001-05-17
AU778829B2 (en) 2004-12-23
CN1390139A (en) 2003-01-08
WO2001034137A3 (en) 2002-02-14
ZA200202822B (en) 2003-09-23
SK6492002A3 (en) 2003-09-11
CZ20021551A3 (en) 2003-02-12
NZ517667A (en) 2004-05-28
TR200201245T2 (en) 2004-08-23
CA2391416A1 (en) 2001-05-17
HUP0204449A2 (en) 2003-04-28
MXPA02004733A (en) 2002-08-30
PE20010701A1 (en) 2001-07-07
EA200200545A1 (en) 2002-12-26
NO20022245D0 (en) 2002-05-10
NO20022245L (en) 2002-07-09
JP2003513916A (en) 2003-04-15
AU1599001A (en) 2001-06-06
KR20020069512A (en) 2002-09-04
HK1050132A1 (en) 2003-06-13
HUP0204449A3 (en) 2006-02-28

Similar Documents

Publication Publication Date Title
AU6048201A (en) Quinazoline derivatives for the treatment of tumours
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
SI1176964T1 (en) Uses of et743 for treating cancer
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
GB9930570D0 (en) Therapy
GB9907243D0 (en) Therapy
AU6062900A (en) Substituted indole compounds and their use for the treatment of cancer
AU8322401A (en) Indole compounds useful for the treatment of cancer
AU1916601A (en) Oncolytic combinations for the treatment of cancer
AU1916501A (en) Oncolytic combinations for the treatment of cancer
HUP0101947A3 (en) Combination for the treatment of tumors
GB9901838D0 (en) Slurry treatment
AU1917101A (en) Oncolytic combinations for the treatment of cancer
AU1595001A (en) Oncolytic combinations for the treatment of cancer
AU1595101A (en) Oncolytic combinations for the treatment of cancer
IL149281A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
GB9819999D0 (en) Treatment of cancer
GB9804361D0 (en) Cancer treatment
AU1592901A (en) Oncolytic combinations for the treatment of cancer
AU2001289127A1 (en) Tumor treatment
AU4598100A (en) Treating cancer
KR100511819B1 (en) Compositions and Methods for the Treatment of Tumor
GB9911183D0 (en) Treatment of cancers
GB9908176D0 (en) Cancer treatment

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)